Company: ACTG
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0000934549-25-000004
Chunk: 15

Company: ACACIA RESEARCH CORP
Filing Date: 2025-03-17
Form: 10-K
Item: Item 8
Chunk 15
---
525 Term loan47,488 — Other long-term liabilities2,091 3,745 Total liabilities203,775 43,936 Commitments and contingencies (Note 15)Stockholders' equity:Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued or outstanding— — Common stock, par value $0.001 per share; 300,000,000 shares authorized; 96,048,999 and 99,895,473 shares issued and outstanding as of December 31, 2024 and 2023, respectively96 100 Treasury stock, at cost, 20,542,064 and 16,183,703 shares as of December 31, 2024 and 2023, respectively(118,542)(98,258)Accumulated other comprehensive income(1,180)— Additional paid-in capital910,237 906,153 Accumulated deficit(275,786)(239,729)Total Acacia Research Corporation stockholders' equity514,825 568,266 Noncontrolling interests37,794 21,343 Total stockholders' equity552,619 589,609 Total liabilities and stockholders' equity$756,394 $633,545 

The accompanying notes are an integral part of these consolidated financial statements.

F-3

ACACIA RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(In thousands, except share and per share data)

Years Ended December 31,20242023Revenues:Intellectual property operations$19,525 $89,156 Industrial operations30,421 35,098 Energy operations49,183 848 Manufacturing operations23,183 — Total revenues122,312 125,102 Costs and expenses:Cost of revenues - intellectual property operations24,551 34,164 Cost of revenues - industrial operations14,912 18,009 Cost of production - energy operations36,291 656 Cost of revenues - manufacturing operations16,904 — Sales and marketing expenses - industrial and manufacturing operations7,217 6,908 General and administrative expenses55,363 44,429 Total costs and expenses155,238 104,166 Operating (loss) income(32,926)20,936 Other (expense) income:Equ